American Journal of Kidney Diseases
Volume 49, Issue 2 , Pages 194-207, February 2007

Target Level for Hemoglobin Correction in Patients With Diabetes and CKD: Primary Results of the Anemia Correction in Diabetes (ACORD) Study

Department of Internal Medicine, University of Heidelberg; Medical Clinic I, University Hospital Mannheim, Germany; Department of Nephrology, Edouard Herriot Hospital, Lyon, France; Education Centre, James Cook University Hospital, Middlesbrough; Department of Renal Medicine, Hope Hospital, Salford, UK; F. Hoffmann-La Roche Ltd, Basel, Switzerland; and Servicio Nefrología, Hospital Universitario La Paz, Madrid, Spain.

Received 14 July 2006; accepted 2 November 2006. published online 02 January 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Originally published online as doi:10.1053/j.ajkd.2006.11.032 on January 3, 2007.Support: The study was sponsored by F. Hoffmann-La Roche Ltd. Potential conflicts of interest: E.R. and D.O. received honoraria as speakers from Hoffmann-La Roche. A.S. and U.B. are employees of F. Hoffmann-La Roche Ltd.Trial registration: www.clinicaltrials.gov; study number: NCT00354341.

PII: S0272-6386(06)01706-9

doi:10.1053/j.ajkd.2006.11.032

Refers to erratum:

  • Erratum

    American Journal of Kidney Diseases April 2007 (Vol. 49, Issue 4, Page 562)

American Journal of Kidney Diseases
Volume 49, Issue 2 , Pages 194-207, February 2007